Interferonopathies

Interferonopathies

Hot
 
0.0
 
5.0 (1)
1412 0 2 0 0
CME Available
Yes
Date
Friday 16 October 2020
Time
10:30 AM - 12:30 PM
Chair(s)
Time converter at worldtimebuddy.com

Add this event to your calendar

AppleGoogleOffice 365OutlookOutlook.comYahoo

Course Description The objectives are to be able to consider interferonopathies in the appropriate context of progressive or static encephalopathies, to learn about their pathogenesis, and possibilities of treatment.

Learning Objectives

  1. Think of a particular group of disorders with variable age of onset and severity, but typical constellation of symptoms.
  2. Start the work-up or where to refer if needed.

Impact Statements

  1. Considering a hereditary disorder in the differential diagnosis of intrauterine infections, cerebral calcifications, or hereditary paraparesis.
  2. Including recessive interferon pathway disorders in any child with slowly progressive or static neurological deficits, particularly when more than one offspring is affected in the family albeit at different degrees.

Organizer: Banu Anlar, MD; Hacettepe University, Ankara, Turkey

Case Presentations Illustrating the Clinical Spectrum
Banu Anlar, MD

Molecular Pathogenesis and Treatment Targets
Adeline Vanderver, MD; Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

Discussion & Questions

ATTENDEE REVIEWS

1 review
Overall rating
 
5.0
Overall quality of the educational activity
 
5.0(1)
Teaching strategy employed
 
5.0(1)
Relevance of the educational activity to your practice
 
5.0(1)
Already have an account? or Create an account
Overall rating
 
5.0
Overall quality of the educational activity
 
5.0
Teaching strategy employed
 
5.0
Relevance of the educational activity to your practice
 
5.0
I want to watch this seminar
Based on your previous knowledge and experience, the level of this activity was
Too Basic
Do you feel that the activity was objective, balanced, and free of commercial bias?
Yes
Was disclosure (financial relationships, unapproved or unlabeled use of drugs or products) made available to you during the activity?
No
NS
Report this review Comments (0) | Was this review helpful? 0 0